NO983875L - Farmas°ytiske midler inneholdende perfluoralkylholdige metallkomplekser, og deres anvendelse ved tumorterapi og intervensjonell radiologi - Google Patents

Farmas°ytiske midler inneholdende perfluoralkylholdige metallkomplekser, og deres anvendelse ved tumorterapi og intervensjonell radiologi

Info

Publication number
NO983875L
NO983875L NO983875A NO983875A NO983875L NO 983875 L NO983875 L NO 983875L NO 983875 A NO983875 A NO 983875A NO 983875 A NO983875 A NO 983875A NO 983875 L NO983875 L NO 983875L
Authority
NO
Norway
Prior art keywords
metal complexes
interventional radiology
tumor therapy
formula
pharmaceuticals
Prior art date
Application number
NO983875A
Other languages
English (en)
Other versions
NO323547B1 (no
NO983875D0 (no
Inventor
Johannes Platzek
Ulrich Niedballa
Chel Bernd Rad
Wolfgang Schlecker
Hanns-Joachim Weinmann
Thomas Frenzel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO983875D0 publication Critical patent/NO983875D0/no
Publication of NO983875L publication Critical patent/NO983875L/no
Publication of NO323547B1 publication Critical patent/NO323547B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19983875A 1996-02-23 1998-08-21 Farmasoytiske midler inneholdende perfluoralkylholdige metallkomplekser, og anvendelse av disse for fremstilling av medikamenter ved tumorterapi og intervensjonell radiologi. NO323547B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19608278A DE19608278A1 (de) 1996-02-23 1996-02-23 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
PCT/EP1997/000684 WO1997030969A1 (de) 1996-02-23 1997-02-14 Pharmazeutische mittel enthaltend perfluoralkylhaltige metallkomplexe und ihre verwendung in der tumortherapie und interventionellen radiologie

Publications (3)

Publication Number Publication Date
NO983875D0 NO983875D0 (no) 1998-08-21
NO983875L true NO983875L (no) 1998-10-22
NO323547B1 NO323547B1 (no) 2007-06-11

Family

ID=7787153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983875A NO323547B1 (no) 1996-02-23 1998-08-21 Farmasoytiske midler inneholdende perfluoralkylholdige metallkomplekser, og anvendelse av disse for fremstilling av medikamenter ved tumorterapi og intervensjonell radiologi.

Country Status (14)

Country Link
EP (1) EP0882010B1 (no)
JP (1) JP2000504736A (no)
AT (1) ATE200894T1 (no)
AU (1) AU1769297A (no)
CA (1) CA2247253A1 (no)
DE (2) DE19608278A1 (no)
DK (1) DK0882010T3 (no)
ES (1) ES2158493T3 (no)
GR (1) GR3036306T3 (no)
NO (1) NO323547B1 (no)
PT (1) PT882010E (no)
TW (1) TW477699B (no)
WO (1) WO1997030969A1 (no)
ZA (1) ZA971537B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919433A (en) * 1996-12-04 1999-07-06 Schering Aktiengesellschaft Macrocyclic metal complex carboxylic acids, their use as well as process for their production
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19731591C2 (de) * 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
ATE320795T1 (de) 2001-08-03 2006-04-15 Glaxo Group Ltd Oberflächenaktive verbindungen und ihre anwendungen
WO2004006934A2 (de) * 2002-07-10 2004-01-22 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecane als modulatoren des guanin-nukleotid bindenden roteins zur behandlung von tumoren
DE102005008309A1 (de) * 2005-02-17 2006-08-24 Schering Ag Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone
ITMI20131225A1 (it) * 2013-07-22 2015-01-23 Miteni Spa Nuovi composti organici fluorurati, procedimento per la loro preparazione e loro uso come intermedi di sintesi
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN110035996B (zh) 2016-11-28 2022-08-09 拜耳医药股份公司 用于磁共振成像的新型高弛豫性钆螯合物
KR20210095168A (ko) 2018-11-23 2021-07-30 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법
JP2024020674A (ja) * 2021-01-06 2024-02-15 Ａｇｃ株式会社 ペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803869C2 (de) * 1978-01-30 1983-12-29 Ethicon, Inc., 08876 Somerville, N.J. Injizierbare Embolisations- und Okklusionslösung
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JP2657393B2 (ja) * 1988-05-18 1997-09-24 日本化薬株式会社 化学塞栓療法剤
FR2682110B1 (fr) * 1991-10-02 1995-05-24 Atta Ligands amphiphiles perfluoroalkyles leurs complexes metalliques et leurs utilisations dans des preparations a usage therapeutique.
WO1993018795A1 (en) * 1992-03-19 1993-09-30 Daikin Industries, Ltd. Mri contrast medium and diagnostic method
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same

Also Published As

Publication number Publication date
WO1997030969A1 (de) 1997-08-28
TW477699B (en) 2002-03-01
ZA971537B (en) 1997-10-30
ES2158493T3 (es) 2001-09-01
NO323547B1 (no) 2007-06-11
EP0882010A1 (de) 1998-12-09
NO983875D0 (no) 1998-08-21
PT882010E (pt) 2001-10-30
DE19608278A1 (de) 1997-08-28
AU1769297A (en) 1997-09-10
DE59703468D1 (de) 2001-06-07
EP0882010B1 (de) 2001-05-02
JP2000504736A (ja) 2000-04-18
CA2247253A1 (en) 1997-08-28
GR3036306T3 (en) 2001-10-31
DK0882010T3 (da) 2001-08-20
ATE200894T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
NO983875L (no) Farmas°ytiske midler inneholdende perfluoralkylholdige metallkomplekser, og deres anvendelse ved tumorterapi og intervensjonell radiologi
IL127352A0 (en) Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosupressives
ATE230403T1 (de) Einige amido- und ammo- substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifische ligande
ES2181006T3 (es) Uso de amidas de acidos de piridil alcanos, piridil alquenos y/o piridil alquinos en el tratamiento de tumores o en inmunosupresion.
NO166267C (no) Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet.
NZ501276A (en) 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
HUP0303665A2 (hu) Káliumcsatorna-blokkoló hatású arilezett furán- és tiofén-karbonsavamidok
MX9301700A (es) Muteinas del factor de necrosis tumoral humano, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
SG154333A1 (en) The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
DK0694545T3 (da) Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder
EA200001061A1 (ru) Фармацевтическая композиция
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
Brown et al. Oxygen abstraction reactions of N-substituted hydroxamic acids with molybdenum (V) and vanadium (III) and-(IV) compounds
ATE172721T1 (de) Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren
ATE260655T1 (de) Verwendung von stickstoffhaltigen aromatischen heterozyklusderivaten zur topischen behandlung von epithelerkrankungen
EP0486045A3 (en) S(+)-phenyl-alkanoic acids and alpha-amino acid containing complexes
DE59705183D1 (de) Therapeutische mittel, enthaltend ebselen gegen asthma
NO943123L (no) 2,3,4,5-tetrahydro-1H-3-benzazepiner og farmasöytisk akseptable syreaddisjonssalter derav
Roach et al. A novel site-directed affinity reagent for cross-linking human hemoglobin: bis [2-(4-phosphonooxyphenoxy) carbonylethyl] phosphinic acid
Boreham Intramolecular Hydrolysis of Glycine Derivatives Coordinated to Cobalt (III) and Some Aspects of Iron Porphyrins Containing Attached Sulphur Groups
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides
ES8300682A1 (es) Procedimiento de preparacion de nuevas carboxamidas
UA48054A1 (uk) Діетиламіноетиламіду-5-метил-2-(1,3,4-тіадіазоліл)-сукцинамінової кислоти гідрохлорид, який проявляє аналгетичну активність
TH33845A (no)
UA6882C2 (uk) Стерилізуючий засіб